| 2D-DIGE | two-dimensional differential gel electrophoresis |
| 2-DE | two-dimensional gel electrophoresis |
| A1AG | α-1-acid-glycoprotein |
| A1BG | α-1-B-glycoprotein |
| ACE | angiotensin-converting enzyme |
| ADEM | acute disseminated encephalomyelitis |
| ALS | amyotrophic lateral sclerosis |
| ANO2 | anoctamine-2 |
| BBB | blood–brain barrier |
| BDNF | brain-derived neurotrophic factor |
| CCL11 | Eotaxin-1 |
| CCL20 | chemokine ligand 20 |
| CCN5 | connective tissue growth factor/cysteine-rich protein/nephroblastoma overexpressed-5 |
| CDMS | clinically definitive multiple sclerosis |
| CHI3L1 | Chitinase-3-like protein 1 |
| CHI3L2 | Chitinase-3-like protein 2 |
| CIDP | chronic inflammatory demyelinating polyneuropathy |
| CIS | clinically isolated syndrome |
| CNS | central nervous system |
| COX5b | cytochrome C oxidase subunit 5b |
| CSF | cerebrospinal fluid |
| DIS | dissemination in space |
| DIT | dissemination in time |
| DMF | dimethyl-fumarate |
| DMT | disease modifying therapy |
| EAE | experimental autoimmune encephalomyelitis |
| EAN | European Academy of Neurology |
| EBV | Epstein–Barr virus |
| ECTRIMS | European Committee for Treatment and Research in Multiple Sclerosis |
| EDSS | expanded disability status scale |
| ELISA | enzyme-linked immunosorbent assay |
| FNG | fingolimod |
| GA | glatiramer-acetate |
| Gd+ | gadolinium |
| GFAP | glial fibrillary acidic protein |
| GPI | glucose-6-phosphate isomerase |
| ICAT | Isotope-coded affinity tag labeling |
| IEC | ion exchange chromatography |
| IFN-β | interferon-β |
| IGF2 | insulin-like growth factor 2 |
| IGFBP7 | insulin-like growth factor-binding protein 7 |
| iTRAQ | isobaric tag for relative and absolute quantitation |
| LC-TMS | liquid chromatography–tandem mass spectrometry |
| LHON | Leber’s Hereditary Optic Neuropathy |
| MAPK | mitogen-activated protein kinase |
| MBP | myelin basic protein |
| MDR | multidrug response |
| MOG | myelin oligodendrocyte glycoprotein |
| MRI | magnetic resonance imaging |
| MS | multiple sclerosis |
| MSSS | multiple sclerosis severity score |
| NAT | natalizumab |
| NEDA | no evidence of disease activity |
| nFL | neurofilament light chain |
| NMOSD | neuromyelitis optica spectrum disorder |
| NMR spectroscopy | nuclear magnetic resonance spectroscopy |
| OGP | oligoclonal gammopathy |
| PEPB1 | phosphatidylethanolamine-binding protein 1 |
| PKCθ | protein kinase C θ |
| PKN | prior knowledge signaling network |
| PLP-1 | proteolipid protein |
| PPMS | primary progressive multiple sclerosis |
| PRDX6 | peroxiredoxin 6 |
| Prx1 | peroxiredoxin-1 |
| QoL | quality of life |
| RAAS | renin–angiotensin–aldosterone system |
| ROS | reactive oxygen species |
| RRMS | relapsing-remitting multiple sclerosis |
| RTN3 | reticulon 3 |
| SAP | serum amyloid P component |
| Scg1 | secretogranin-1 |
| SDS-PAGE | sodium dodecyl sulfate-polyacrylamide gel electrophoresis |
| SEC | size exclusion chromatography |
| SERPINA3 | α-1-antichymotrypsin |
| SILAC | stable isotope labeling with amino acids in cell culture |
| SIRTs | silent information regulator proteins |
| SLE | systemic lupus erythematosus |
| SPMS | secondary progressive multiple sclerosis |
| SST | somatostatin |
| STAT | signal transducer and activator of transcription |
| TAK1 | TGF-β-activated kinase 1 |
| TER | teriflunomide |
| TGF-β | transforming growth factor beta |
| TNF | tumor necrosis factor |
| VILIP-1 | visinin-like protein |
| vWF | von Willebrand factor |